Related Experiment Video
Updated: Mar 24, 2026

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Dietary palmitic acid inhibits colorectal cancer progression through enhancing bisecting GlcNAc
Lei Lei1, Juan Tang1, Yuejiao Lv1
1Key Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, Xi'an, China.
Abstract:
Glycosylation changes are pivotal in colorectal cancer (CRC) development. The role of bisecting GlcNAc, a specific N-glycosylation type catalyzed by glycosyltransferase MGAT3, in CRC progression remains elusive. Previous studies indicated that dietary interventions can be beneficial for patients with certain congenital disorders of glycosylation. However, the impact of dietary fatty acids, such as palmitic acid (PA), on glycosylation regulation remains largely unclear. Here, we observed markedly decreased levels of bisecting GlcNAc and MGAT3 in colonic tissues of CRC patients. Downregulation of bisecting GlcNAc in CRC cells increased cell proliferation, migration, and invasion, while decreasing apoptosis. Moreover, a PA-rich diet inhibited CRC carcinogenesis in azoxymethane/dextran sodium sulfate-induced CRC mice by elevating bisecting GlcNAc levels. However, in Mgat3fl/fl Villin-Cre mice the inhibitory effects of the PA-rich diet were abolished. Intact glycopeptide analysis revealed that PA enhanced the bisecting GlcNAc modification on desmoglein 2 (DSG2). Additionally, DSG2 was identified to inhibit CRC carcinogenesis through the EGFR/AKT signaling pathway. In conclusion, dietary PA suppresses CRC carcinogenesis by regulating bisecting GlcNAc modification on DSG2, providing a direct mechanistic link between dietary fatty acids and CRC.
Insights
Dietary palmitic acid (PA) suppresses colorectal cancer (CRC) by increasing bisecting N-acetylglucosamine (GlcNAc) levels. This modification on desmoglein 2 (DSG2) inhibits cancer progression via the EGFR/AKT pathway.
Area of Science:
- Oncology
- Glycobiology
- Nutritional Science
Background:
- Aberrant glycosylation, particularly bisecting N-acetylglucosamine (GlcNAc), is implicated in colorectal cancer (CRC) development.
- The enzyme MGAT3 catalyzes bisecting GlcNAc, but its role and regulation in CRC are not fully understood.
- The influence of dietary fatty acids, like palmitic acid (PA), on glycosylation in CRC remains largely unexplored.
Purpose of the Study:
- To investigate the role of bisecting GlcNAc and MGAT3 in colorectal cancer (CRC).
- To determine the impact of dietary palmitic acid (PA) on CRC progression and glycosylation.
- To elucidate the molecular mechanisms linking dietary PA, glycosylation, and CRC carcinogenesis.
Main Methods:
- Analysis of bisecting GlcNAc and MGAT3 levels in human CRC tissues and cell lines.
- Assessment of cell proliferation, migration, invasion, and apoptosis in CRC cells with altered bisecting GlcNAc levels.
- Utilizing azoxymethane/dextran sodium sulfate-induced CRC mouse models, including Mgat3-deficient mice, to evaluate the effects of a PA-rich diet.
- Intact glycopeptide analysis to identify PA-modified glycoproteins, followed by investigation of the EGFR/AKT signaling pathway.
Main Results:
- Decreased bisecting GlcNAc and MGAT3 levels were observed in human CRC tissues.
- Reduced bisecting GlcNAc in CRC cells correlated with increased proliferation, migration, invasion, and decreased apoptosis.
- A PA-rich diet suppressed CRC development in mice by upregulating bisecting GlcNAc, an effect dependent on MGAT3.
- Palmitic acid (PA) was found to enhance bisecting GlcNAc modification on desmoglein 2 (DSG2), which inhibits CRC carcinogenesis via the EGFR/AKT pathway.
Conclusions:
- Dietary palmitic acid (PA) exerts a protective effect against colorectal cancer (CRC) carcinogenesis.
- This suppression is mediated by PA-induced enhancement of bisecting N-acetylglucosamine (GlcNAc) modification on desmoglein 2 (DSG2).
- The findings establish a direct mechanistic link between dietary fatty acids and CRC suppression through specific glycosylation patterns.
Related Concept Videos
Cancer Prevention
Some...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Lipid Digestion

